Filing Flows › Cardiff Oncology (CRDF) › Recalls, complaints & regulation
Cardiff Oncology (CRDF): clinical trials
Cardiff Oncology (CRDF) beyond its filings: 1 active clinical trial.
Cardiff Oncology's latest quarter
Cardiff Oncology, Q2 2026: revenue $104K (-14% year over year), net loss $9.2M, operating cash flow −$11.8M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Cardiff Oncology have?
1 active study on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.